Skip to main content

Table 1 Patient and biopsy information from the tumors of paired (tumor and normal from the same breast) tissue samples.

From: Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma

Patient No. Diagnosisa SBR Gradeb Age ERc PRc Malignant lymph nodesd
1 IDC III/III 43 - - NS
2 IDC III/III 55 - - 0/11
3 IDC III/III 67 - - 0/17
4 IDC III/III 49 - - NS
5 IDC III/III 59 +++ +++ 0/9
6 IDC III/III 75 - - 0/10
7 IDC II/III 60 - - 15/15
8 IDC III/III 34 - - 1/15
9 IDC III/III 70 ++++ - 0/5
10 IDC II/III 69 na na 0/16
11 IDC III/III 49 ++ + 0/8
  1. a IDC: infiltrating duct carcinoma b SBR: Scarff-Bloom-Richardson histological grading system c ER and PR concentration codes: - receptor values less than 24 + receptor values between 25 and 99 ++ receptor values between 100 and 249 +++ receptor values between 250 and 549 ++++ receptor values > 550 d Number of lymph nodes assessed as malignant out of total number examined na: not available NS: No lymph nodes submitted with specimen
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us